Largest pharmaceutical companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceutical companies ranked by net assets, at NOK 837.6B, ahead of Johnson & Johnson (NOK 789.8B) and Sanofi (NOK 767.1B). Figures as of 18 Nov 2026, 18:41 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerNOK 837.6B
- Median
- NOK 8.5B
- Combined market value
- NOK 49.33T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | NOK 837.6B | NOK 1.56T | NOK 273.10 | 0.97% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | NOK 789.8B | NOK 6.42T | NOK 2,667.93 | 1.17% down | 38% up | ||
| 3 | SanofiSNY · Health Care | NOK 767.1B | NOK 1.1T | NOK 458.54 | 0.40% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | NOK 509.5B | NOK 3.31T | NOK 1,341.44 | 3.40% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | NOK 504.9B | NOK 1.75T | NOK 1,012.29 | 0.19% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | NOK 471.4B | NOK 2.7T | NOK 1,740.68 | 1.40% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | NOK 450.7B | NOK 662.1B | NOK 207.23 | 1.13% down | 54% up | ||
| 8 | NovartisNVS · Health Care | NOK 446.8B | NOK 2.85T | NOK 1,511.41 | 1.94% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | NOK 302.8B | NOK 950B | NOK 9,183.55 | 1.01% down | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | NOK 278.9B | NOK 1.69T | NOK 384.00 | 2.59% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | NOK 257B | NOK 12.04T | NOK 13,520.00 | 1.39% down | 35% up | ||
| 12 | GSKGSK · Health Care | NOK 210.6B | NOK 947.9B | NOK 472.87 | 0.85% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | NOK 180.8B | NOK 1.32T | NOK 5,220.93 | 0.90% up | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | NOK 178.9B | NOK 1.19T | NOK 583.20 | 1.86% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | NOK 142.5B | NOK 229.5B | NOK 200.16 | 1.05% up | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | NOK 94.1B | NOK 386.6B | NOK 672.41 | 1.08% up | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 76.6B | NOK 476.5B | NOK 408.41 | 1.07% down | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | NOK 68.7B | NOK 240.5B | NOK 5,646.29 | 0.20% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | NOK 63.4B | NOK 130.5B | NOK 261.04 | 4.26% up | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | NOK 59B | NOK 113.6B | NOK 586.73 | 3.53% up | 11% up | ||
| 21 | GrifolsGRFS · Health Care | NOK 56.6B | NOK 55.8B | NOK 81.99 | 1.91% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | NOK 56.6B | NOK 307.7B | NOK 498.98 | 0.86% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | NOK 43.9B | NOK 270.6B | NOK 373.49 | 0.39% down | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | NOK 42.2B | NOK 448.4B | NOK 3,925.47 | 1.93% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | NOK 41.8B | NOK 153.6B | NOK 2,393.28 | 2.65% up | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 38.9B | NOK 121.5B | NOK 145.76 | 1.75% up | 5% up | ||
| 27 | ZoetisZTS · Health Care | NOK 32.3B | NOK 335.1B | NOK 824.72 | 1.99% up | 29% down | ||
| 28 | AlkermesALKS · Health Care | NOK 17.6B | NOK 76.5B | NOK 455.05 | 3.37% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | NOK 9.9B | NOK 58.3B | NOK 2,913.81 | 2.39% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | NOK 9.7B | NOK 30.5B | NOK 157.30 | 0.81% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | NOK 8.5B | NOK 83.6B | NOK 2,991.54 | 1.24% up | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | NOK 7.6B | NOK 195.9B | NOK 1,462.35 | 3.53% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | NOK 7.5B | NOK 62B | NOK 1,526.81 | 0.06% down | 31% up | ||
| 34 | InsmedINSM · Health Care | NOK 7.2B | NOK 256.5B | NOK 1,169.01 | 0.96% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | NOK 6.9B | NOK 89.1B | NOK 938.68 | 3.30% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | NOK 6.4B | NOK 81.6B | NOK 102.04 | 1.27% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | NOK 6.3B | NOK 96.8B | NOK 640.10 | 5.38% up | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | NOK 6.3B | NOK 72.4B | NOK 661.46 | 2.54% down | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | NOK 6.2B | NOK 47.5B | NOK 273.24 | 1.29% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | NOK 6B | NOK 79.7B | NOK 1,221.02 | 1.11% up | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 5.8B | NOK 91.8B | NOK 3,953.12 | 3.29% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 5.5B | NOK 72.6B | NOK 923.37 | 0.23% up | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | NOK 5.1B | NOK 44.3B | NOK 404.78 | 0.59% down | 88% up | ||
| 44 | ABIVAXABVX · Health Care | NOK 4.9B | NOK 71.2B | NOK 813.63 | 2.31% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | NOK 4.8B | NOK 47.7B | NOK 846.76 | 0.51% up | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | NOK 4.7B | NOK 44.9B | NOK 269.81 | 3.32% up | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | NOK 4.6B | NOK 63.2B | NOK 931.90 | 0.11% down | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 4.5B | NOK 59.5B | NOK 421.15 | 1.14% up | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | NOK 3.2B | NOK 38.4B | NOK 280.27 | 1.51% down | 169% up | ||
| 50 | ErascaERAS · Health Care | NOK 3.1B | NOK 46B | NOK 130.96 | 2.66% down | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | NOK 3B | NOK 58.4B | NOK 895.23 | 0.52% up | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 1.3B | NOK 80.6B | NOK 1,162.91 | 2.96% up | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | NOK 1.1B | NOK 47.6B | NOK 495.93 | 0.20% up | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | NOK 855.2M | NOK 68.6B | NOK 1,304.13 | 0.96% down | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -NOK 685.7M | NOK 74.6B | NOK 214.01 | 4.62% up | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -NOK 1.2B | NOK 51B | NOK 1,207.66 | 0.76% down | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -NOK 1.7B | NOK 172.7B | NOK 2,633.35 | 0.25% up | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -NOK 2B | NOK 48.9B | NOK 584.84 | 0.03% up | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -NOK 6.4B | NOK 69.7B | NOK 500.33 | 0.01% up | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -NOK 20.2B | NOK 147.5B | NOK 757.16 | 1.78% up | 17% up | ||
| 61 | AbbVieABBV · Health Care | -NOK 31.7B | NOK 4.92T | NOK 2,785.71 | 1.78% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6861 NOK).
Questions and answers
Which pharmaceutical companies rank first by net assets?
Pfizer (NOK 837.6B), Johnson & Johnson (NOK 789.8B) and Sanofi (NOK 767.1B) are the top three of the 61 pharmaceutical companies ranked by net assets as of 18 Nov 2026, 18:41 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by net assets.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by net assets have a combined market value of NOK 49.33T as of 18 Nov 2026, 18:41 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.